Innovative Biologics

Innovative Biologics focuses on developing advanced biological products that enhance operational efficiency and user engagement across various sectors. Established in 2003 and headquartered in Herndon, US, Innovative Biologics specializes in creating innovative biological solutions. The company raised funding of USD 0. 10 mn in its most recent deal on October 2, 2007, from Virginia Venture Partners.

It has completed one deal in total. Innovative Biologics offers a variety of core products that address specific needs in its target markets. These solutions are designed to streamline operations and improve user experience for both businesses and individual consumers. The company operates in North America and Europe, focusing on delivering adaptable products that cater to unique challenges faced by its clients.

Revenue is generated through a structured model that includes both direct-to-consumer sales and partnerships with retailers. The company primarily engages clients through subscription services, allowing ongoing access to its products. Flagship offerings are positioned at premium price points, reflecting their value, and tiered pricing plans are likely available to accommodate varying user needs. Innovative Biologics plans to leverage its recent funding of USD 0.

10 mn raised in October 2007 to support the development of new products and expand into additional geographic regions. The company is focusing on launching new solutions aimed at enhancing operational efficiency and user satisfaction. Specific new markets and regions targeted for expansion will be determined as part of this growth strategy.